Mirum Pharmaceuticals (MIRM) Cash from Operations (2019 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Cash from Operations of 228763000.0 for Q1 2026, down 11565.63% year-over-year from N/an in Q1 2025, and down 3870.61% quarter-over-quarter from 6067000.0 in Q4 2025.
Mirum Pharmaceuticals (MIRM) Cash from Operations (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Cash from Operations history runs 8 years deep, the most recent figure standing at 228763000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 11565.63% year-over-year to 228763000.0; the TTM figure through Mar 2026 stood at 170975000.0 (down 2396.71% YoY), while the FY2025 annual figure was 55827000.0, up 440.7% from the prior year.
- Cash from Operations for Q1 2026 stood at 228763000.0, down from 6067000.0 in the prior quarter.
- The five-year high for Cash from Operations was 39681000.0 in Q3 2025, with the low at 228763000.0 in Q1 2026.
- The 5-year median for Cash from Operations is 16618000.0 (2023), against an average of 20805352.94.
- The sharpest annual moves came in 2025 and 2026: Cash from Operations jumped 896.01% in 2025, then sank 11565.63% in 2026.
- Mirum Pharmaceuticals' Cash from Operations stood at 34270000.0 in 2022, then jumped by 51.51% to 16618000.0 in 2023, then jumped by 69.5% to 5068000.0 in 2024, then jumped by 219.71% to 6067000.0 in 2025, then sank by 3870.61% to 228763000.0 in 2026.
- Business Quant data shows MIRM's Cash from Operations at 228763000.0 in Q1 2026, 6067000.0 in Q4 2025, and 39681000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn | -44.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -44.25 Mn |
| Jun 30, 2026 | -44.25 Mn |
| Mar 31, 2026 | -228.76 Mn |
| Mar 31, 2026 | -228.76 Mn |
| Dec 31, 2025 | 6.07 Mn |
| Dec 31, 2025 | 6.07 Mn |
| Sep 30, 2025 | 39.68 Mn |
| Sep 30, 2025 | 39.68 Mn |
| Jun 30, 2025 | 12.04 Mn |
| Jun 30, 2025 | 12.04 Mn |
| Mar 31, 2025 | -1.96 Mn |
| Mar 31, 2025 | -1.96 Mn |
| Dec 31, 2024 | -5.07 Mn |
| Dec 31, 2024 | -5.07 Mn |
| Sep 30, 2024 | 3.98 Mn |
| Sep 30, 2024 | 3.98 Mn |
| Jun 30, 2024 | -3.80 Mn |
| Jun 30, 2024 | -3.80 Mn |
| Mar 31, 2024 | 15.21 Mn |
| Mar 31, 2024 | 15.21 Mn |